Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • Is There Any Good Reason Left to Delay Hepatitis C Treatment?

    Physicians increasingly argue that the best choice is to get rid of hepatitis C right away. But your insurance company may not agree. How risky is it to wait for treatment?

    17 April 2015 | Poz
  • WHO Issues Guideline For Manufacturers Of Generic Hepatitis C Medicine

    The World Health Organization has issued a guidance document on the design of bioequivalence studies for a leading hepatitis C medicine. Generic drug companies seeking prequalification by the WHO need to demonstrate that their generic version is equivalent to the originator drug.

    08 April 2015 | Intellectual Property Watch
  • We Asked Foreign Born British HIV Patients About Nigel Farage's 'Health Tourist' Comments

    Has Nigel Farage got a point? Can a few thousand foreign born HIV patients be held responsible for the NHS's financial black hole? I went to meet some of these HIV positive "health tourists" to find out how their holidays are going and ask whether it would be cheaper for everyone if they they just went somewhere and died.

    07 April 2015 | Vice
  • Providers have mixed feelings about prescribing HIV prevention

    National survey finds providers’ perspectives lag behind PrEP guidelines: The survey was the first to be conducted since the U.S. Public Health Service released detailed PrEP guidelines in May 2014. In the Web-based survey fewer than half of 324 practitioners, most of them HIV specialists, fewer than half reported being “very likely” to prescribe PrEP to their patients who are high-risk heterosexuals or people who use intravenous drugs. For some other prime candidates—HIV-negative men whose male partners have the virus—79 percent of providers reported being very likely to prescribe the regimen.

    07 April 2015 | Group Health Research Institute
  • HIV-positive man slams Nigel Farage for 'deeply offensive' remarks

    Nigel Farage’s decision to use the TV debate to attack the number of foreign nationals receiving treatment for HIV has been attacked as “deeply offensive” by campaigners – including a Nigerian man whose life is being prolonged by the NHS. Bisi Alimi, 40, was diagnosed with HIV in 2004 but was unable to access treatment in Nigeria for fear of being revealed to be a homosexual. When he was outed in 2007 he came to the UK.

    07 April 2015 | Independent
  • HIV: are 60% of those diagnosed not British nationals?

    Analysis of Nigel Farage's claim: both the number and proportion given are inaccurate, and the data available records country of birth, not nationality.

    07 April 2015 | Full Fact
  • Do foreigners come to the UK to get HIV treatment?

    Experts say there is no evidence to support Nigel Farage’s claim that foreigners come to Britain primarily to access life-saving HIV treatment.

    03 April 2015 | The Guardian
  • Alert: Serbia is losing harm reduction

    The situation with harm reduction in Serbia is getting increasingly alarming after withdrawal of the Global Fund. Three organizations doing HR programs in Serbia for more than a decade are struggling to maintain services. We want a different future for their beneficiaries. ""Please use your communication with donors to put Serbia back as eligible for funding the harm reduction programs - we keep knocking on closed doors. The EU is the biggest donor here and has no health programs whatsoever; as for other donors, we are ineligible whomever we approach, and keep losing on relevance to the calls,“ says Miodrag Atanasjevic, NGO Veza, Belgrade, Serbia.

    02 April 2015 | Eurasian Harm Reduction Network
  • MSM and transgender people are absent from the Global Fund country dialogue in Eastern Europe and Central Asia

    Men who have sex with men (MSM) and transgender people (TG) are not involved in strategic discussions around HIV in most nations of Eastern Europe and Central Asia (EECA). Lack of reliable epidemiological data, high stigma, and policies that restrict the access of MSM and TG to information on HIV preclude the two key populations from meaningfully participating in the country dialogue processes.

    01 April 2015 | EATG
  • Aetna to Lower Costs for Most HIV Drugs After Complaint

    Aetna Inc. has agreed to reduce out-of-pocket payments for most HIV and AIDS medicines after pressure from an advocacy group, revising coverage that had some patients paying $1,000 a month for the drugs.

    30 March 2015 | Bloomberg
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.